This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Japan Tobacco Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: The Innovations of Sotaro Takigawa
Introduction
Sotaro Takigawa is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of pain and interstitial cystitis. His innovative approach has led to the development of a unique therapeutic agent.
Latest Patents
Takigawa holds a patent for a method of treating pain or interstitial cystitis using an indole compound. The patent describes a therapeutic or prophylactic agent comprising N-[2-(6,6-dimethyl-4,5,6,7-tetrahydro-H-indazol-3-yl)-1H-indol-6-yl]-N-methyl-(2S)-2-(morpholin-4-yl)propanamide or a pharmaceutically acceptable salt thereof. This invention showcases his commitment to advancing medical treatments.
Career Highlights
Sotaro Takigawa is associated with Japan Tobacco Inc., where he continues to work on innovative solutions in the pharmaceutical sector. His career reflects a dedication to research and development, contributing to the advancement of therapeutic methods.
Collaborations
Takigawa has collaborated with notable colleagues, including Yoshifumi Ueda and Mutsuyoshi Matsushita. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Sotaro Takigawa's contributions to the field of medicine through his patent and collaborations highlight his role as a significant inventor. His work continues to impact the treatment of pain and interstitial cystitis, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile